Quick Takeaways
- Commodore Capital LP filed SCHEDULE 13G/A for Bright Minds Biosciences Inc. Common Shares, without par value (DRUG).
- Disclosed ownership: 7.2%.
- Date of event: 31 Dec 2024.
Commodore Capital LP - 31 Dec 2024 SCHEDULE 13G/A Report for Bright Minds Biosciences Inc. Common Shares, without par value (DRUG)
- Filing Manager
- Commodore Capital LP
- Reporting Manager
- COMMODORE CAPITAL LP
- Symbol
- DRUG
- Shares outstanding
- 6,944,444 shares
- Disclosed Ownership
- 500,000 shares
- Ownership
- 7.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:05:23 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Commodore Capital LP disclosed 7.2% ownership in Bright Minds Biosciences Inc. Common Shares, without par value (DRUG) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| COMMODORE CAPITAL LP | 7.2% | 500,000 | 0 | 500,000 | /s/ Michael Kramarz | Michael Kramarz, Managing Partner | |
| Commodore Capital Master LP | 7.2% | 500,000 | 0 | 500,000 | /s/ Michael Kramarz | Michael Kramarz, Authorized Signatory |